This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Prof. Mohamed Hassanein, consultant Endocrinologist, Dubai hospital, Chair of DAR international alliance, presenting safety and effectiveness of insulin glargine 300 U/ml in participants with T2DM who fast during Ramadan in Gulf region.
MAT-BH-2200398/V1/April2022
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.